N-(3-(3-(4-(6-(6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-ylamino)pyridin-3-yl)piperazin-1-yl)propanamido)propyl)acrylamide

ID: ALA4872623

PubChem CID: 164623523

Max Phase: Preclinical

Molecular Formula: C33H43N9O4

Molecular Weight: 629.77

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C=CC(=O)NCCCNC(=O)CCN1CCN(c2ccc(Nc3ncc4c(C)c(C(C)=O)c(=O)n(C5CCCC5)c4n3)nc2)CC1

Standard InChI:  InChI=1S/C33H43N9O4/c1-4-28(44)34-13-7-14-35-29(45)12-15-40-16-18-41(19-17-40)25-10-11-27(36-20-25)38-33-37-21-26-22(2)30(23(3)43)32(46)42(31(26)39-33)24-8-5-6-9-24/h4,10-11,20-21,24H,1,5-9,12-19H2,2-3H3,(H,34,44)(H,35,45)(H,36,37,38,39)

Standard InChI Key:  XEYPGBRCMYQGQM-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 46 50  0  0  0  0  0  0  0  0999 V2000
   29.2455  -10.9784    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.2455  -11.7956    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.9508  -12.2001    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.9508  -10.5657    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.6561  -10.9784    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.6545  -11.7938    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.3587  -12.2011    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.0650  -11.7941    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.0627  -10.9756    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.3579  -10.5720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.5384  -12.2052    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.9508   -9.7485    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.5366  -10.5719    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.5342   -9.7547    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.8301  -10.9826    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.9553  -13.0204    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.2949  -13.5017    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5486  -14.2786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.3658  -14.2774    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.6171  -13.4998    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.7731  -12.2020    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.4804  -11.7927    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.1869  -12.2032    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.8937  -11.7946    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.8933  -10.9765    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.1802  -10.5688    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.4763  -10.9798    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.6001  -10.5663    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.3087  -10.9732    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.5981   -9.7491    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.3049   -9.3389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.0136   -9.7458    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.7203   -9.3355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.0155  -10.5630    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.4290   -9.7425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.1357   -9.3322    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.8444   -9.7392    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   39.1338   -8.5151    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   40.5511   -9.3289    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.2598   -9.7359    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.9666   -9.3256    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.6752   -9.7326    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   43.3820   -9.3223    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.0906   -9.7293    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.7974   -9.3190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.3801   -8.5052    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  4  2  0
  2  3  1  0
  3  6  1  0
  5  4  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  2 11  2  0
  4 12  1  0
  1 13  1  0
 13 14  2  0
 13 15  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 16  1  0
  3 16  1  0
  8 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
 25 28  1  0
 28 29  1  0
 28 30  1  0
 30 31  1  0
 29 34  1  0
 31 32  1  0
 32 33  1  0
 32 34  1  0
 33 35  1  0
 35 36  1  0
 36 37  1  0
 36 38  2  0
 37 39  1  0
 39 40  1  0
 40 41  1  0
 41 42  1  0
 42 43  1  0
 43 44  1  0
 44 45  2  0
 43 46  2  0
M  END

Alternative Forms

  1. Parent:

    ALA4872623

    ---

Associated Targets(Human)

NCI-H1299 (3248 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-453 (1139 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 629.77Molecular Weight (Monoisotopic): 629.3438AlogP: 2.88#Rotatable Bonds: 13
Polar Surface Area: 154.45Molecular Species: NEUTRALHBA: 11HBD: 3
#RO5 Violations: 2HBA (Lipinski): 13HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.34CX Basic pKa: 7.87CX LogP: 2.12CX LogD: 1.52
Aromatic Rings: 3Heavy Atoms: 46QED Weighted: 0.15Np Likeness Score: -1.13

References

1. Shan H, Ma X, Yan G, Luo M, Zhong X, Lan S, Yang J, Liu Y, Pu C, Tong Y, Li R..  (2021)  Discovery of a novel covalent CDK4/6 inhibitor based on palbociclib scaffold.,  219  [PMID:33857728] [10.1016/j.ejmech.2021.113432]

Source